Adzenys XR-ODT Is Sweet as Candy, Strong as Adderrall, Legal for Kids
The pharma amphetamine is FDA-approved to be popped by six-year-olds.
Adzenys is a dissolvible, and said-to-be flavorful pharmaceutical amphetamine. The brand's extended release pill, the XR-ODT, is being marketed as a medication for children six and older with attention deficit hyperactivity disorder (ADHD). The dope is said to be as effective as Adderrall.
"Adzenys, an extended-release amphetamine, was approved by the Food and Drug Administration in January for patients 6 years and older.
Some psychiatrists worry that Adzenys will accelerate a trend toward overmedicating kids—and could be yet another gateway into ADHD drug abuse."
The Centers for Disease Control and Prevention says ADHD affects five percent of children. And the shared aesthetic between branding for tasty candy and sales materials for the Adzenys XR-ODT has some psychiatrists reportedly predicting the pill's youth appeal might lead to increased amphetamine abuse.
Adzenys's predecessors: Adderrall, Ritalin, and Vyvanse are all approved as ADHD meds. These drugs are also widely perceived, and popped, by users who see them as performance enhancing chemicals. The "study drugs" are given credit for fueling all-night cram sessions and increased productivity at the office. Modanifil, which is marketed as a narcolepsy treatment, is often compared to the ficticious "Limitless pill," which has the reputation for turning takers into real go-getters. Adzenys is also kind of reminiscent of Gushers.
The sale of ADHD-meds via white-coat-written prescriptions is projected to reach more than $15 billion by 2020.